There are very serious costs to excessive safety regulation. When it makes drug development more expensive, marginal drugs don't get put through trials, and tho

There are very serious costs to excessive safety regulation. When it makes drug development more expensive, marginal drugs don't get put through trials, and those drugs then never reach patients. Rational analysis means weighing the cost of each additional safety rule against the benefit. In many cases, there's a lot of evidence that the benefits of the current IRB process are trivial or nonexistent, and the costs are large.